← Open Payments lookup

DAVID URRATE: Open Payments

NPI 1598872871 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,232 in 234 payments from 16 companies in 2025. Trend: 2023 $2,959 · 2024 $2,958 · 2025 $3,232

Food & beverage: $3,218Education: $14
CompanyPaymentsAmount
Alkermes, Inc.38$647
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)37$587
Otsuka America Pharmaceutical, Inc.19$347
ABBVIE INC.21$257
Axsome Therapeutics, Inc.21$253
Takeda Pharmaceuticals U.S.A., Inc.21$240
Collegium Pharmaceutical, Inc.18$180
Neurocrine BioSciences, Inc.18$179
Janssen Pharmaceuticals, Inc20$141
Lundbeck LLC6$113

Products named: ARISTADA, CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, Auvelity, Jornay PM, INGREZZA.

Industry payments across TX — which companies pay providers there.